When is high-dose intravenous iron repletion needed? Assessing new treatment options
David GozzardBetsi Cadwaladr University Health Board, Llandudno, Wales, UKAbstract: High doses of intravenous iron have a role in the treatment of a number of clinical situations associated with iron deficiency, iron deficiency anemia, and blood loss. In the presence of functioning erythropoiesis, i...
Saved in:
Main Author: | David Gozzard (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Options for intravenous iron supplementation in hemodialysis patients
by: Ji Yoon Kong, et al.
Published: (2020) -
Lack of efficacy of ergocalciferol repletion
by: Thomas Wasser, et al.
Published: (2012) -
T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies
by: Emmanuel Katsanis, et al.
Published: (2020) -
The use of intravenous iron in pregnancy: for whom and when? A survey of Australian and New Zealand obstetricians
by: Sarah Smith-Wade, et al.
Published: (2020) -
New treatment options for iron deficiency in women of different ages
by: Yu.E. Dobrokhotova, et al.
Published: (2022)